ETX — E-Therapeutics Share News
0.000.00%
Last trade - 00:00- £54.93m
- £23.53m
- £0.48m
Interim results for six months ended 31 July 2021
RNAi Platform Characterisation Results
Investor Presentation
Patent Filing Applications
Notice of Interim Results
Commencement of trading on the OTCQX Best Market
Second Price Monitoring Extn
Price Monitoring Extension
Total Voting Rights
Director Dealing and Issue of Equity
Brief: e-Therapeutics Says Further Milestone In Galapagos Collaboration
Further milestone in Galapagos collaboration
Total Voting Rights
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Result of AGM
Brief: E-Therapeutics Says Alison Gallafent Appointed Head Of Intellectual Property For Co